|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
|
|
|
(State or other jurisdiction of
incorporation or organization)
|
|
(IRS Employer
Identification No.)
|
|
|
|
|
||
|
||
(Address of Principal Executive Offices, zip code)
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
|
|
|
|
☒
|
Accelerated filer
|
☐
|
Non-accelerated filer
|
☐
|
Smaller Reporting Company
|
|
Emerging growth company
|
|
As of November 1, 2022, there were
F-1 | |
F-2 | |
F-4 | |
F-5 | |
F-6 | |
F-8 | |
F-10 | |
3 | |
17 | |
18 | |
19 | |
19 | |
19 | |
19 | |
19 | |
19 | |
20 | |
20 |
PART I. FINANCIAL INFORMATION
September 30,
2022
|
December 31,
2021
|
|||||||
ASSETS
|
||||||||
CURRENT ASSETS:
|
||||||||
Cash and cash equivalents
|
$
|
|
$
|
|
||||
Marketable securities
|
|
|
||||||
Trade receivables, net of allowances of $
|
|
|
||||||
Inventories, net
|
|
|
||||||
Prepaid expenses and other current assets
|
|
|
||||||
Total current assets
|
|
|
||||||
LONG-TERM ASSETS:
|
||||||||
Marketable securities
|
|
|
||||||
Deferred tax assets, net
|
|
|
||||||
Property, plant and equipment, net
|
|
|
||||||
Operating lease right-of-use assets, net
|
|
|
||||||
Intangible assets, net
|
|
|
||||||
Goodwill
|
|
|
||||||
Other long-term assets
|
|
|
||||||
Total long-term assets
|
|
|
||||||
Total assets
|
$
|
|
$
|
|
F - 2
September 30,
2022
|
December 31,
2021 |
|||||||
LIABILITIES AND STOCKHOLDERS’ EQUITY
|
||||||||
CURRENT LIABILITIES:
|
||||||||
Trade payables, net
|
$
|
|
$
|
|
||||
Employees and payroll accruals
|
|
|
||||||
Warranty obligations
|
|
|
||||||
Deferred revenues and customers advances
|
|
|
||||||
Accrued expenses and other current liabilities
|
|
|
||||||
Total current liabilities
|
|
|
||||||
LONG-TERM LIABILITIES:
|
||||||||
Convertible senior notes, net
|
|
|
||||||
Warranty obligations
|
|
|
||||||
Deferred revenues
|
|
|
||||||
Finance lease liabilities
|
|
|
||||||
Operating lease liabilities
|
|
|
||||||
Other long-term liabilities
|
|
|
||||||
Total long-term liabilities
|
|
|
||||||
COMMITMENTS AND CONTINGENT LIABILITIES
|
||||||||
STOCKHOLDERS’ EQUITY:
|
||||||||
Common stock of $
|
|
|
||||||
Additional paid-in capital
|
|
|
||||||
Accumulated other comprehensive loss
|
( |
)
|
( |
)
|
||||
Retained earnings
|
|
|
||||||
Total stockholders’ equity
|
|
|
||||||
Total liabilities and stockholders’ equity
|
$
|
|
$
|
|
F - 3
Three Months Ended
September 30, |
Nine Months Ended
September 30, |
|||||||||||||||
2022
|
2021
|
2022
|
2021
|
|||||||||||||
Revenues
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
Cost of revenues
|
|
|
|
|
||||||||||||
Gross profit
|
|
|
|
|
||||||||||||
Operating expenses:
|
||||||||||||||||
Research and development
|
|
|
|
|
||||||||||||
Sales and marketing
|
|
|
|
|
||||||||||||
General and administrative
|
|
|
|
|
||||||||||||
Other operating expenses (income), net
|
(
|
) |
|
|
|
|
||||||||||
Total operating expenses
|
|
|
|
|
||||||||||||
Operating income
|
|
|
|
|
||||||||||||
Financial expense, net
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
) | ||||||||
Other income |
||||||||||||||||
Income before income taxes
|
|
|
|
|
||||||||||||
Income taxes
|
|
|
|
|
||||||||||||
Net income
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
Net basic earnings per share of common stock
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
Net diluted earnings per share of common stock
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
Weighted average number of shares used in computing net basic earnings per share of common stock
|
|
|
|
|
||||||||||||
Weighted average number of shares used in computing net diluted earnings per share of common stock
|
|
|
|
|
The accompanying notes are an integral part of the condensed consolidated financial statements.
F - 4
Three Months Ended
September 30, |
Nine Months Ended
September 30, |
|||||||||||||||
2022
|
2021
|
2022
|
2021
|
|||||||||||||
Net income
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
Other comprehensive income (loss), net of tax:
|
||||||||||||||||
Net change related to available-for-sale securities
|
( |
)
|
|
|
( |
)
|
(
|
)
|
||||||||
Net change related to cash flow hedges
|
( |
)
|
|
( |
)
|
|
||||||||||
Foreign currency translation adjustments on intra-entity transactions that are of a long-term investment nature
|
(
|
)
|
(
|
) |
(
|
)
|
(
|
)
|
||||||||
Foreign currency translation adjustments, net
|
|
|
(
|
) |
(
|
)
|
(
|
)
|
||||||||
Total other comprehensive loss
|
( |
)
|
(
|
) |
( |
)
|
(
|
)
|
||||||||
Comprehensive income (loss)
|
$
|
( |
)
|
$
|
|
$
|
( |
)
|
$
|
|
The accompanying notes are an integral part of the condensed consolidated financial statements.
F - 5
Common stock |
Additional |
Accumulated
other
|
||||||||||||||||||||||
Number
|
Amount
|
paid in
Capital
|
comprehensive
loss
|
Retained
earnings
|
Total
|
|||||||||||||||||||
Balance as of January 1, 2022
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
$
|
|
||||||||||||
Issuance of common stock upon exercise of stock-based awards
|
|
*
|
|
|
|
|
||||||||||||||||||
Stock based compensation
|
-
|
|
|
|
|
|
||||||||||||||||||
Issuance of common stock in a secondary public offering, net of underwriters' discounts and commissions of $
|
|
|
|
|
|
|
||||||||||||||||||
Other comprehensive loss adjustments
|
-
|
|
|
(
|
)
|
|
(
|
)
|
||||||||||||||||
Net income
|
-
|
|
|
|
|
|
||||||||||||||||||
Balance as of March 31, 2022
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
$
|
|
||||||||||||
Issuance of Common Stock upon exercise of stock-based awards
|
|
*
|
|
|
|
|
||||||||||||||||||
Issuance of Common stock under employee stock purchase plan
|
|
*
|
|
|
|
|
||||||||||||||||||
Stock based compensation
|
-
|
|
|
|
|
|
||||||||||||||||||
Other comprehensive loss adjustments
|
-
|
|
|
(
|
)
|
|
(
|
)
|
||||||||||||||||
Net income
|
-
|
|
|
|
|
|
||||||||||||||||||
Balance as of June 30, 2022
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
$
|
|
||||||||||||
Issuance of Common Stock upon exercise of stock-based awards |
* |
|||||||||||||||||||||||
Stock based compensation |
- | |||||||||||||||||||||||
Other comprehensive loss adjustments |
- |
( |
) |
( |
) | |||||||||||||||||||
Net income |
- |
|
|
|||||||||||||||||||||
Balance as of September 30, 2022 |
$ | $ | $ |
( |
) | $ |
|
$ |
|
F - 6
Common stock |
Additional |
Accumulated
other
|
||||||||||||||||||||||
Number
|
Amount
|
paid in
Capital
|
comprehensive
income (loss)
|
Retained
earnings
|
Total
|
|||||||||||||||||||
Balance as of January 1, 2021
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
|||||||||||||
Cumulative effect of adopting ASU 2020-06
|
-
|
|
(
|
)
|
|
|
(
|
)
|
||||||||||||||||
Issuance of Common Stock upon exercise of stock-based awards
|
|
*
|
|
|
|
|
||||||||||||||||||
Stock based compensation
|
-
|
|
|
|
|
|
||||||||||||||||||
Other comprehensive loss adjustments
|
-
|
|
|
(
|
)
|
|
(
|
)
|
||||||||||||||||
Net income
|
-
|
|
|
|
|
|
||||||||||||||||||
Balance as of March 31, 2021
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
$
|
|
||||||||||||
Issuance of Common Stock upon exercise of stock-based awards
|
|
*
|
|
|
|
|
||||||||||||||||||
Stock based compensation
|
-
|
|
|
|
|
|
||||||||||||||||||
Other comprehensive income adjustments
|
-
|
|
|
|
|
|
||||||||||||||||||
Net income
|
-
|
|
|
|
|
|||||||||||||||||||
Balance as of June 30, 2021
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
$
|
|
||||||||||||
Issuance of Common Stock upon exercise of stock-based awards |
* |
|||||||||||||||||||||||
Stock based compensation |
- | |||||||||||||||||||||||
Other comprehensive loss adjustments |
- | ( |
) | ( |
) | |||||||||||||||||||
Net income |
- | |||||||||||||||||||||||
Balance as of September 30, 2021 |
$ | $ | $ | ( |
) | $ | $ |
F - 7
Nine Months Ended
September 30, |
||||||||
2022
|
2021
|
|||||||
Cash flows from operating activities:
|
||||||||
Net income
|
$
|
|
$
|
|
||||
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
|
||||||||
Depreciation of property, plant and equipment
|
|
|
||||||
Amortization of intangible assets
|
|
|
||||||
Amortization of debt discount and debt issuance costs
|
|
|
||||||
Amortization of premium and accretion of discount on available-for-sale marketable securities, net
|
|
|
||||||
Impairment of goodwill and intangible assets
|
|
|
||||||
Stock-based compensation expenses
|
|
|
||||||
Gain from sale of privately held company |
( |
) | ||||||
Deferred income taxes, net
|
( |
)
|
(
|
)
|
||||
Loss (gain) from sale and disposal of assets
|
( |
) |
|
|||||
Exchange rate fluctuations and other items, net
|
|
|
||||||
Changes in assets and liabilities:
|
||||||||
Inventories, net
|
( |
)
|
|
|||||
Prepaid expenses and other assets
|
( |
)
|
(
|
)
|
||||
Trade receivables, net
|
( |
)
|
(
|
)
|
||||
Trade payables, net
|
|
|
(
|
)
|
||||
Employees and payroll accruals
|
|
|
||||||
Warranty obligations
|
|
|
||||||
Deferred revenues and customers advances
|
|
|
||||||
Other liabilities, net
|
|
|
||||||
Net cash provided by (used in) operating activities
|
( |
)
|
|
|||||
Cash flows from investing activities:
|
||||||||
Proceed from sales and maturities of available-for-sale marketable securities
|
|
|
||||||
Purchase of property, plant and equipment
|
( |
) |
(
|
)
|
||||
Investment in available-for-sale marketable securities
|
( |
) |
(
|
)
|
||||
Investment in a privately-held company |
( |
) | ||||||
Proceeds from sale of a privately-held company
|
|
|
||||||
Withdrawal from bank deposits, net |
|
|||||||
Payment for asset acquisition, net of cash acquired |
|
( |
) | |||||
Other investing activities
|
|
|
||||||
Net cash used in investing activities
|
$
|
( |
)
|
$
|
(
|
) |
F - 8
Nine Months Ended
September 30, |
||||||||
2022
|
2021
|
|||||||
Cash flows from financing activities:
|
||||||||
Proceeds from secondary public offering, net of issuance costs
|
$
|
|
$
|
|
||||
Repayment of bank loans
|
( |
) |
(
|
)
|
||||
Proceeds from exercise of stock-based awards
|
|
|
||||||
Tax withholding in connection with stock-based awards, net
|
( |
)
|
( |
) |
||||
Other financing activities
|
( |
)
|
(
|
)
|
||||
Net cash provided by (used in) financing activities
|
|
(
|
)
|
|||||
Increase (decrease) in cash and cash equivalents
|
|
(
|
)
|
|||||
Cash and cash equivalents at the beginning of the period
|
|
|
||||||
Effect of exchange rate differences on cash and cash equivalents
|
( |
)
|
(
|
)
|
||||
Cash and cash equivalents at the end of the period
|
$
|
|
$
|
|
||||
Supplemental disclosure of non-cash activities:
|
||||||||
Right-of-use asset recognized with a corresponding lease liability
|
$
|
|
$
|
|
F - 9
a. |
SolarEdge Technologies, Inc. (the “Company”) and its subsidiaries design, develop, and sell an intelligent inverter solution designed to maximize power generation at the individual photovoltaic (“PV”) module level while lowering the cost of energy produced by the solar PV system and providing comprehensive and advanced safety features. The Company’s products consist mainly of (i) power optimizers designed to maximize energy throughput from each and every module through constant tracking of Maximum Power Point individually per module, (ii) inverters which invert direct current (DC) from the PV module to alternating current (AC) including the Company’s future ready energy hub inverter which supports, among other things, connection to a DC- coupled battery for backup capabilities, (iii) a remote cloud-based monitoring platform, that collects and processes information from the power optimizers and inverters to enable customers and system owners, to monitor and manage the solar PV system (iv) a residential storage and backup solution which includes a company designed and manufactured lithium-ion DC-coupled battery that is used to increase energy independence and maximize self-consumption for homeowners including a battery, and (v) additional smart energy management solutions.
|
b. |
The Company has expanded its activity to other areas of smart energy technology organically and through acquisitions. The Company now offers a variety of energy solutions, which include lithium-ion cells, batteries, and energy storage systems (“Energy Storage”), full powertrain kits for electric vehicles, or EVs (“e-Mobility”), as well as automated machines for industrial use (“Automation Machines”). |
c. |
Basis of Presentation:
|
d. |
Use of estimates:
|
F - 10
SOLAREDGE TECHNOLOGIES INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
(in thousands, except per share data)
e. |
Concentrations of supply risks:
|
f. |
New accounting pronouncements not yet adopted:
|
g. |
Recently issued and adopted pronouncements:
|
F - 11
SOLAREDGE TECHNOLOGIES INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
(in thousands, except per share data)
Amortized
cost |
Gross unrealized
gains
|
Gross unrealized
losses
|
Fair value
|
|||||||||||||
Available-for-sale – matures within one year:
|
||||||||||||||||
Corporate bonds
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
|||||||
Governmental bonds
|
|
|
(
|
)
|
|
|||||||||||
|
|
(
|
)
|
|
||||||||||||
Available-for-sale – matures after one year:
|
||||||||||||||||
Corporate bonds
|
|
|
(
|
)
|
|
|||||||||||
Governmental bonds
|
|
|
(
|
)
|
|
|||||||||||
|
|
(
|
)
|
|
||||||||||||
Total
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
Amortized
cost |
Gross unrealized
gains
|
Gross unrealized
losses
|
Fair value
|
|||||||||||||
Available-for-sale – matures within one year:
|
||||||||||||||||
Corporate bonds
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
|||||||
Governmental bonds
|
|
|
(
|
)
|
|
|||||||||||
|
|
(
|
)
|
|
||||||||||||
Available-for-sale – matures after one year:
|
||||||||||||||||
Corporate bonds
|
|
|
(
|
)
|
|
|||||||||||
Governmental bonds
|
|
|
(
|
)
|
|
|||||||||||
|
|
(
|
)
|
|
||||||||||||
Total
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
F - 12
SOLAREDGE TECHNOLOGIES INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
(in thousands, except per share data)
September 30,
2022
|
December 31,
2021
|
|||||||
Raw materials
|
$
|
|
$
|
|
||||
Work in process
|
|
|
||||||
Finished goods
|
|
|
||||||
$
|
|
$
|
|
F - 13
SOLAREDGE TECHNOLOGIES INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
(in thousands, except per share data)
NOTE 5: DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES
As of September 30, 2022, the Company entered into forward contracts and put and call options to sell U.S. dollars (“USD”) for NIS in the amount of approximately NIS
In addition to the above-mentioned cash flow hedge transactions, the Company also entered into derivative instrument arrangements to hedge the Company’s exposure to currencies other than the USD. These derivative instruments are not designated as cash flow hedges, as defined by ASC 815, and therefore all gains and losses, resulting from fair value remeasurement, were recorded immediately in the statement of income, under "Financial expense, net".
The Company classifies cash flows related to its hedging as operating activities in its condensed consolidated statement of cash flows.
As of September 30, 2022, the Company entered into forward contracts to sell Australian dollars (“AUD”) for USD in the amount of AUD
As of September 30, 2022, the Company entered into forward contracts to sell Euro for USD in the amount of €
The fair values of outstanding derivative instruments were as follows:
Balance sheet location
|
September 30,
2022
|
December 31,
2021
|
|||||||
Derivative assets of options and forward contracts:
|
|||||||||
Designated cash flow hedges
|
Prepaid expenses and other current assets
|
$
|
|
$
|
|
||||
Non-designated hedges
|
Prepaid expenses and other current assets
|
|
|
||||||
Total derivative assets
|
$
|
|
$
|
|
|||||
Derivative liabilities of options and forward contracts:
|
|||||||||
Designated cash flow hedges
|
Accrued expenses and other current liabilities
|
$
|
(
|
)
|
$
|
|
|||
Non-designated hedges
|
Accrued expenses and other current liabilities
|
|
(
|
)
|
|||||
Total derivative liabilities
|
$
|
(
|
)
|
$
|
(
|
)
|
F - 14
SOLAREDGE TECHNOLOGIES INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
(in thousands, except per share data)
Gains (losses) on derivative instruments recognized in our income statements are summarized below:
|
|
Three Months Ended September 30, |
|
Nine Months Ended September 30, |
|
|
||||
|
|
2022 |
|
2021 |
|
2022 |
|
2021 |
|
Affected line item |
Foreign exchange contracts |
|
|
|
|
|
|
|
|
|
|
Non Designated Hedging Instruments |
|
$ |
|
$ |
|
$ |
|
$ |
|
Financial expenses, net |
See Note 13 for information regarding gains (losses) from designated hedging instruments reclassified from accumulated other comprehensive loss.
Gains (losses) on derivative instruments recognized in the consolidated comprehensive income (loss) statements were as follows:
|
Three Months Ended |
Nine Months Ended |
||||||||||||||
|
2022 |
2021 |
2022 |
2021 |
||||||||||||
Foreign exchange contracts: |
||||||||||||||||
Designated Hedging Instruments |
$ |
( |
) |
$ |
|
$ |
( |
) |
$ |
|
F - 15
SOLAREDGE TECHNOLOGIES INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
(in thousands, except per share data)
Fair value measurements as of
|
||||||||||
Description
|
Fair Value
Hierarchy
|
September 30,
2022
|
December 31,
2021
|
|||||||
Assets:
|
||||||||||
Cash equivalents:
|
||||||||||
Cash
|
Level 1
|
$
|
|
$
|
|
|||||
Money market mutual funds
|
Level 1
|
$
|
|
$
|
|
|||||
Deposits
|
Level 1
|
$
|
|
$
|
|
|||||
Derivative instruments
|
Level 2
|
$
|
|
$
|
|
|||||
Short-term marketable securities:
|
||||||||||
Corporate bonds
|
Level 2
|
$
|
|
$
|
|
|||||
Governmental bonds
|
Level 2
|
$
|
|
$
|
|
|||||
Long-term marketable securities:
|
||||||||||
Corporate bonds
|
Level 2
|
$
|
|
$
|
|
|||||
Governmental bonds
|
Level 2
|
$
|
|
$
|
|
|||||
Liabilities:
|
||||||||||
Derivative instruments
|
Level 2
|
$
|
(
|
)
|
$
|
(
|
)
|
Three Months Ended
September 30,
|
Nine Months Ended
September 30,
|
|||||||||||||||
2022
|
2021
|
2022
|
2021
|
|||||||||||||
Balance, at the beginning of the period
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
Additions and adjustments to cost of revenues
|
|
|
|
|
||||||||||||
Usage and current warranty expenses
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||||
Balance, at end of the period
|
|
|
|
|
||||||||||||
Less current portion
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||||
Long term portion
|
$
|
|
$
|
|
$
|
|
$
|
|
F - 16
SOLAREDGE TECHNOLOGIES INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
(in thousands, except per share data)
Three Months Ended
September 30,
|
Nine Months Ended
September 30,
|
|||||||||||||||
2022
|
2021
|
2022
|
2021
|
|||||||||||||
Balance, at the beginning of the period
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
Revenue recognized
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||||
Increase in deferred revenues and customer advances
|
|
|
|
|
||||||||||||
Balance, at the end of the period
|
|
|
|
|
||||||||||||
Less current portion
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||||
Long term portion
|
$
|
|
$
|
|
$
|
|
$
|
|
2022
|
$
|
|
||
2023
|
|
|||
2024
|
|
|||
2025
|
|
|||
2026
|
|
|||
Thereafter
|
|
|||
Total deferred revenues
|
$
|
|
September 30,
2022
|
December 31,
2021
|
|||||||
Accrued expenses
|
$
|
|
$
|
|
||||
Government authorities
|
|
|
||||||
Operating lease liabilities
|
|
|
||||||
Provision for legal claims
|
|
|
||||||
Accrual for sales incentives
|
|
|
||||||
Other
|
|
|
||||||
$
|
|
$
|
|
F - 17
SOLAREDGE TECHNOLOGIES INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
(in thousands, except per share data)
September 30,
2022
|
December 31,
2021
|
|||||||
Liability:
|
||||||||
Principal
|
$
|
|
$
|
|
||||
Unamortized issuance costs
|
(
|
)
|
(
|
)
|
||||
Net carrying amount
|
$
|
|
$
|
|
F - 18
SOLAREDGE TECHNOLOGIES INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
(in thousands, except per share data)
F - 19
SOLAREDGE TECHNOLOGIES INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
(in thousands, except per share data)
Number of options
|
Weighted average
exercise price
|
Weighted average
remaining contractual
term in years
|
Aggregate intrinsic
Value
|
|||||||||||||
Outstanding as of December 31, 2021
|
|
$
|
|
|
$
|
|
||||||||||
Exercised
|
(
|
)
|
|
- |
|
|||||||||||
Forfeited or expired
|
(
|
)
|
|
- |
- |
|||||||||||
Outstanding as of September 30, 2022
|
|
$
|
|
|
$
|
|
||||||||||
Vested and expected to vest as of September 30, 2022
|
|
$
|
|
|
$
|
|
||||||||||
Exercisable as of September 30, 2022
|
|
$
|
|
|
$
|
|
Number of RSUs
|
Weighted average
grant date fair value
|
|||||||
Unvested as of December 31, 2021
|
|
$
|
|
|||||
Granted
|
|
|
||||||
Vested
|
(
|
)
|
|
|||||
Forfeited
|
(
|
)
|
|
|||||
Unvested as of September 30, 2022
|
|
$
|
|
Number of PSUs
|
Weighted average
grant date fair value
|
|||||||
Unvested as of December 31, 2021
|
|
$
|
|
|||||
Granted
|
|
|
||||||
Unvested as of September 30, 2022
|
|
$
|
|
The ESPP is implemented through an offering every six months. According to the ESPP, eligible employees may use up to
F - 20
SOLAREDGE TECHNOLOGIES INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
(in thousands, except per share data)
Three Months Ended
September 30,
|
Nine Months Ended
September 30,
|
|||||||||||||||
2022
|
2021
|
2022
|
2021
|
|||||||||||||
Cost of revenues
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
Research and development
|
|
|
|
|
||||||||||||
Selling and marketing
|
|
|
|
|
||||||||||||
General and administrative
|
|
|
|
|
||||||||||||
Total stock-based compensation expenses
|
$
|
|
$
|
|
$
|
|
$
|
|
The Company capitalized stock-based compensation as part of inventories and prepaid expenses for the three and nine months ended September 30, 2022, in the amount of $
The total tax benefit associated with share-based compensation for the three months ended September 30, 2022 and 2021 was $
The total tax benefit associated with share-based compensation for the nine months ended September 30, 2022, and 2021 was $
As of September 30, 2022, there were total unrecognized compensation expenses in the amount of $
F - 21
SOLAREDGE TECHNOLOGIES INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
(in thousands, except per share data)
The Company has contractual obligations to purchase goods and raw materials. These contractual purchase obligations relate to inventories and other purchase orders, which cannot be canceled without penalty. In addition, the Company acquires raw materials or other goods and services, including product components, by issuing authorizations to its suppliers to purchase materials based on its projected demand and manufacturing needs.
F - 22
SOLAREDGE TECHNOLOGIES INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
(in thousands, except per share data)
Three Months Ended
September 30,
|
Nine Months Ended
September 30,
|
|||||||||||||||
2022
|
2021
|
2022
|
2021
|
|||||||||||||
Unrealized gains (losses) on available-for-sale marketable securities
|
||||||||||||||||
Beginning balance
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
|
|||||
Revaluation
|
(
|
)
|
|
|
(
|
)
|
(
|
)
|
||||||||
Tax on revaluation
|
|
|
|
|
||||||||||||
Other comprehensive income (loss) before reclassifications
|
(
|
)
|
|
|
(
|
)
|
(
|
)
|
||||||||
Reclassification
|
|
(
|
) |
|
(
|
) | ||||||||||
Tax on reclassification
|
(
|
) |
|
(
|
)
|
|
||||||||||
Gains (losses) reclassified from accumulated other comprehensive income (loss)
|
|
(
|
) |
|
(
|
) | ||||||||||
Net current period other comprehensive income (loss)
|
(
|
)
|
|
|
(
|
)
|
(
|
)
|
||||||||
Ending balance
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
||||
Unrealized gains (losses) on cash flow hedges
|
||||||||||||||||
Beginning balance
|
$
|
(
|
) |
$
|
|
|
$
|
|
$
|
|
||||||
Revaluation
|
(
|
)
|
|
(
|
)
|
|
||||||||||
Tax on revaluation
|
|
(
|
)
|
|
(
|
)
|
||||||||||
Other comprehensive income (loss) before reclassifications
|
(
|
)
|
|
(
|
)
|
|
||||||||||
Reclassification
|
|
(
|
)
|
|
(
|
)
|
||||||||||
Tax on reclassification
|
(
|
)
|
|
(
|
)
|
|
||||||||||
Gains (losses) reclassified from accumulated other comprehensive income (loss)
|
|
(
|
)
|
|
(
|
)
|
||||||||||
Net current period other comprehensive income (loss)
|
(
|
)
|
|
(
|
)
|
|
||||||||||
Ending balance
|
$
|
(
|
)
|
$
|
|
$
|
(
|
)
|
$
|
|
||||||
Foreign currency translation adjustments on intra-entity transactions that are of a long-term investment in nature
|
||||||||||||||||
Beginning balance
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
|
|||||
Revaluation
|
(
|
)
|
(
|
) |
(
|
)
|
(
|
)
|
||||||||
Ending balance
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
||||
Unrealized gains (losses) on foreign currency translation
|
||||||||||||||||
Beginning balance
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
|
|||||
Revaluation
|
|
|
(
|
) |
(
|
)
|
(
|
)
|
||||||||
Ending balance
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
||||
Total
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
F - 23
SOLAREDGE TECHNOLOGIES INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
(in thousands, except per share data)
Details about Accumulated Other
Comprehensive Loss Components
|
Three Months Ended
September 30,
|
Nine Months Ended
September 30,
|
Affected Line Item in the
Statement of Income
|
||||||||||||||
2022
|
2021
|
2022
|
2021
|
||||||||||||||
Unrealized gains (losses) on available-for-sale marketable securities |
|||||||||||||||||
$
|
(
|
$
|
|
$
|
(
|
)
|
$
|
|
Financial expense, net
|
||||||||
|
|
|
(
|
) |
Income taxes
|
||||||||||||
$
|
(
|
$
|
|
$
|
(
|
)
|
$
|
|
Total, net of income taxes
|
||||||||
Unrealized gains (losses) on cash flow hedges, net |
|||||||||||||||||
(
|
)
|
|
(
|
)
|
|
Cost of revenues
|
|||||||||||
(
|
)
|
|
(
|
)
|
|
Research and development
|
|||||||||||
(
|
)
|
|
(
|
)
|
|
Sales and marketing
|
|||||||||||
(
|
)
|
|
(
|
)
|
|
General and administrative
|
|||||||||||
$
|
(
|
)
|
$
|
|
$
|
(
|
)
|
$
|
|
Total, before income taxes
|
|||||||
|
(
|
)
|
|
(
|
)
|
Income taxes
|
|||||||||||
(
|
)
|
|
(
|
)
|
|
Total, net of income taxes
|
|||||||||||
Total reclassifications for the period
|
$
|
(
|
)
|
$
|
|
$
|
(
|
)
|
$
|
|
Three Months Ended
September 30,
|
Nine Months Ended
September 30,
|
|||||||||||||||
2022
|
2021
|
2022
|
2021
|
|||||||||||||
Impairment of goodwill and intangible assets (1)
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
Write-off of property, plant and equipment
|
(
|
) |
|
|
|
|||||||||||
Sale of property, plant and equipment |
( |
) | ( |
) | ||||||||||||
Sale of Critical Power assets |
( |
) | ( |
) | ||||||||||||
Kokam purchase escrow (2)
|
|
|
|
|
(
|
)
|
||||||||||
Total other operating expenses (income)
|
$
|
(
|
) |
$
|
|
|
$
|
|
$
|
|
F - 24
SOLAREDGE TECHNOLOGIES INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
(in thousands, except per share data)
NOTE 15: INCOME TAXES
The effective tax rate for the three months ended September 30, 2022, and 2021 was
The increase in the effective tax rate in the current year, is primarily due to the change to Section 174 of the U.S Internal Revenue Code, which came into effect on January 1, 2022. The change requires taxpayers to amortize research and development expenditures over five years (if expensed by a U.S. entity) or fifteen years (if expensed by non-U.S. entities). This change resulted in an increase in the Company’s taxable income and Global Intangible Low Taxed Income (“GILTI”) tax. In addition, the change in the Company's tax rate resulted from a different allocation of income among the Company’s U.S., Israeli, and foreign subsidiaries, and lower tax benefits relating to stock-based compensation.
As of September 30, 2022, and December 31, 2021, unrecognized tax benefits were $
The Company accrues interest and penalties related to unrecognized tax benefits in its provision for income taxes. The total amount of penalties and interest were immaterial as of September 30, 2022, and December 31, 2021.
In August 2022, the U.S. government signed into law the Inflation Reduction Act of 2022 (the “IRA”), which, among other things, revised U.S. tax law by, including a new corporate alternative minimum tax (the “CAMT”) of
F - 25
SOLAREDGE TECHNOLOGIES INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
(in thousands, except per share data)
Three Months Ended
September 30,
|
Nine Months Ended
September 30,
|
|||||||||||||||
2022
|
2021
|
2022
|
2021
|
|||||||||||||
Basic EPS:
|
||||||||||||||||
Numerator:
|
||||||||||||||||
Net income
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
Denominator:
|
||||||||||||||||
Shares used in computing net EPS of common stock, basic
|
|
|
|
|
||||||||||||
Diluted EPS:
|
||||||||||||||||
Numerator:
|
||||||||||||||||
Net income attributable to common stock, basic
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
Notes due 2025
|
|
|
|
|
||||||||||||
Net income attributable to common stock, diluted
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
Denominator:
|
||||||||||||||||
Shares used in computing net EPS of common stock, basic
|
|
|
|
|
||||||||||||
Notes due 2025
|
|
|
|
|
||||||||||||
Effect of stock-based awards
|
|
|
|
|
||||||||||||
Shares used in computing net EPS of common stock, diluted
|
|
|
|
|
||||||||||||
Shares excluded from the calculation of diluted net EPS due to their anti-dilutive effect
|
|
|
|
|
F - 26
SOLAREDGE TECHNOLOGIES INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
(in thousands, except per share data)
Three Months Ended
September 30, 2022 |
Nine Months Ended
September 30, 2022 |
|||||||||||||||
Solar
|
All other
|
Solar
|
All other
|
|||||||||||||
Revenues
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
Cost of revenues
|
|
|
|
|
||||||||||||
Gross profit
|
|
|
|
|
||||||||||||
Research and development
|
|
|
|
|
|
|
|
|
||||||||
Sales and marketing
|
|
|
|
|
||||||||||||
General and administrative
|
|
|
|
|
||||||||||||
Segments profit (loss)
|
$
|
|
$
|
(
|
)
|
$
|
|
$
|
(
|
)
|
F - 27
SOLAREDGE TECHNOLOGIES INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
(in thousands, except per share data)
Three Months Ended
September 30, 2021 |
Nine Months Ended
September 30, 2021 |
|||||||||||||||
Solar
|
All other
|
Solar
|
All other
|
|||||||||||||
Revenues
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
Cost of revenues
|
|
|
|
|
||||||||||||
Gross profit
|
|
|
|
|
||||||||||||
Research and development
|
|
|
|
|
|
|
|
|
||||||||
Sales and marketing
|
|
|
|
|
||||||||||||
General and administrative
|
|
|
|
|
||||||||||||
Segments profit (loss)
|
$
|
|
$
|
(
|
)
|
$
|
|
$
|
(
|
)
|
Three Months Ended
September 30,
|
Nine Months Ended
September 30,
|
|||||||||||||||
2022
|
2021
|
2022
|
2021
|
|||||||||||||
Solar revenues
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
All other revenues
|
|
|
|
|
||||||||||||
Revenues from finance component
|
|
|
|
|
||||||||||||
Consolidated revenues
|
$
|
|
$
|
|
$
|
|
$
|
|
Three Months Ended
September 30,
|
Nine Months Ended
September 30,
|
|||||||||||||||
2022
|
2021
|
2022
|
2021
|
|||||||||||||
Solar segment profit
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
All other segment loss
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||||
Segments operating profit
|
|
|
|
|
||||||||||||
Amounts not allocated to segments:
|
||||||||||||||||
Stock based compensation expenses
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||||
Amortization related to business combinations |
( |
) |
( |
) |
( |
) |
( |
) | ||||||||
Impairment of goodwill and intangible assets
|
|
|
|
(
|
)
|
|
||||||||||
Disposal of assets related to Critical Power
|
|
|
|
(
|
)
|
|
||||||||||
Sale of Critical Power assets |
||||||||||||||||
Other unallocated income (expenses), net
|
|
|
|
|
|
|
(
|
)
|
||||||||
Consolidated operating income
|
$
|
|
$
|
|
$
|
|
$
|
|
NOTE 18: SUBSEQUENT EVENTS
On November 3, 2022, the Company received notice that a class action lawsuit was filed in the U.S District Court of the Southern District of New York against the Company, SolarEdge Technologies Ltd., the Company’s CEO and the Company’s CFO, by a purported stockholder of the Company, alleging violations of the Federal Securities Act in connection with complaints filed against the Company by Ampt LLC, the details for which can be found under “Note 12- Commitments and Contingent Liabilities”. The Company believes the allegations contained in this new action are without merit and intends to vigorously defend against them.
F - 28
• | future demand for renewable energy including solar energy solutions; |
• | changes to net metering policies or the reduction, elimination or expiration of government subsidies and economic incentives for on-grid solar energy applications; |
• | changes in the U.S. trade environment, including the imposition of import tariffs; |
• | federal, state, and local regulations governing the electric utility industry with respect to solar energy; |
• | changes in tax laws, tax treaties, and regulations or the interpretation of them, including the Inflation Reduction Act; |
• | the retail price of electricity derived from the utility grid or alternative energy sources; |
• | interest rates and supply of capital in the global financial markets in general and in the solar market specifically; |
• | competition, including introductions of power optimizer, inverter and solar photovoltaic (“PV”) system monitoring products by our competitors; |
• | developments in alternative technologies or improvements in distributed solar energy generation; |
• | historic cyclicality of the solar industry and periodic downturns; |
• | product quality or performance problems in our products; |
• | our ability to forecast demand for our products accurately and to match production with demand; |
• | our dependence on ocean transportation to timely deliver our products in a cost-effective manner; |
• | our dependence upon a small number of outside contract manufacturers and limited or single source suppliers; |
• | capacity constraints, delivery schedules, manufacturing yields, and costs of our contract manufacturers and availability of components; |
• | delays, disruptions, and quality control problems in manufacturing; |
• | shortages, delays, price changes, or cessation of operations or production affecting our suppliers of key components; |
• | existing and future responses to and effects of Covid-19; |
• | business practices and regulatory compliance of our raw material suppliers; |
• | performance of distributors and large installers in selling our products; |
• | disruption in our global supply chain and rising prices of oil and raw materials as a result of the conflict between Russia and Ukraine may adversely affect our business; |
• | our customers’ financial stability, creditworthiness, and debt leverage ratio; |
• | our ability to retain key personnel and attract additional qualified personnel; |
• | our ability to effectively design, launch, market, and sell new generations of our products and services; |
• | our ability to maintain our brand and to protect and defend our intellectual property; |
• | our ability to retain, and events affecting, our major customers; |
• | our ability to manage effectively the growth of our organization and expansion into new markets; |
• | our ability to integrate acquired businesses; |
• | fluctuations in global currency exchange rates; |
• | unrest, terrorism, or armed conflict in Israel; |
• | macroeconomic conditions in our domestic and international markets, as well as inflation concerns, rising interest rates and recessionary concerns; |
• | consolidation in the solar industry among our customers and distributors; |
• | our ability to service our debt; and |
• | the other factors set forth under “Item 1A. Risk Factors” in our annual report on Form 10-K for the year ended December 31, 2021 and subsequent reports on Form 10-Q and in other documents we file from time to time with the SEC that disclose risks and uncertainties that may affect our business. |
Three Months Ended September 30, 2022 | Nine Months Ended September 30, 2022 | |||||||||||||||
2022 | 2021 | 2022 | 2021 | |||||||||||||
Inverters shipped | 264,515 | 230,849 | 704,018 | 592,300 | ||||||||||||
Power optimizers shipped | 6,123,479 | 4,699,443 | 17,062,684 | 13,445,523 | ||||||||||||
Megawatts shipped1 | 2,703 | 1,903 | 7,349 | 5,237 | ||||||||||||
Megawatts shipped - residential batteries | 321 | 11 | 671 | 11 |
Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||
2022 | 2021 | 2022 | 2021 | |||||||||||||
(In thousands) | ||||||||||||||||
Revenues | $ | 836,723 | $ | 526,404 | $ | 2,219,577 | $ | 1,411,950 | ||||||||
Cost of revenues | 614,722 | 353,843 | 1,635,976 | 943,123 | ||||||||||||
Gross profit | 222,001 | 172,561 | 583,601 | 468,827 | ||||||||||||
Operating expenses: | ||||||||||||||||
Research and development | 69,659 | 55,666 | 210,855 | 155,307 | ||||||||||||
Sales and marketing | 42,726 | 29,383 | 117,017 | 85,752 | ||||||||||||
General and administrative | 27,933 | 21,098 | 82,483 | 60,317 | ||||||||||||
Other operating expenses (income), net | (2,724 | ) | — | 1,963 | 1,350 | |||||||||||
Total operating expenses | 137,594 | 106,147 | 412,318 | 302,726 | ||||||||||||
Operating income | 84,407 | 66,414 | 171,283 | 166,101 | ||||||||||||
Financial expense, net | (33,025 | ) | (5,751 | ) | (52,785 | ) | (13,591 | ) | ||||||||
Other income | 7,533 | — | 7,533 | — | ||||||||||||
Income before income taxes | 58,915 | 60,663 | 126,031 | 152,510 | ||||||||||||
Income taxes | 34,172 | 7,615 | 53,081 | 24,294 | ||||||||||||
Net income | 24,743 | 53,048 | 72,950 | 128,216 |
Three months ended September 30, 2022 to 2021 | Nine months ended September 30, 2022 to 2021 | |||||||||||||||||||||||||||||||
2022 | 2021 | Change | 2022 | 2021 | Change | |||||||||||||||||||||||||||
(In thousands) | ||||||||||||||||||||||||||||||||
Revenues | 836,723 | 526,404 | 310,319 | 59.0 | % | 2,219,577 | 1,411,950 | 807,627 | 57.2 | % |
Three months ended September 30, 2022 to 2021 | Nine months ended September 30, 2022 to 2021 | |||||||||||||||||||||||||||||||
2022 | 2021 | Change | 2022 | 2021 | Change | |||||||||||||||||||||||||||
(In thousands) | ||||||||||||||||||||||||||||||||
Cost of revenues | 614,722 | 353,843 | 260,879 | 73.7 | % | 1,635,976 | 943,123 | 692,853 | 73.5 | % | ||||||||||||||||||||||
Gross profit | 222,001 | 172,561 | 49,440 | 28.7 | % | 583,601 | 468,827 | 114,774 | 24.5 | % |
• | an increase in the volume of products sold and the increase in the unit cost of components used in the manufacturing of our products; |
• | a significant increase in shipment and logistic costs in an aggregate amount of $25.4 million due to (i) an increase in shipment rates; and (ii) an increase in volumes shipped; |
• | an increase in other production costs of $17.8 million, which is mainly attributed to charges from our contract manufacturers due to manufacturing disruptions related to global supply constraints, increased logistics costs resulting from transportation disruptions and the mobilization of components between our different manufacturing sites and ramp up costs associated with our new contract manufacturing site in Mexico; |
• | an increase in warranty expenses and warranty accruals of $13.7 million associated primarily with an increase in the number of products in our install base as well as an increase in costs related to the different elements of our warranty expenses which include the cost of the products, shipment and other related expenses; |
• | an increase in custom duties of $5.0 million attributed to higher tariff charges due to an increase in volumes sold; and |
• | an increase in personnel-related costs of $4.8 million related to the expansion of our production, operations, and support headcount which grew in parallel to our growing install base worldwide. |
• | an increase in the volume of products sold and an increase in the unit cost of components used in the manufacturing of our products; |
• | a significant increase in shipment and logistic costs in an aggregate amount of $92.8 million due to (i) an increase in shipment rates; and (ii) an increase in volumes shipped; |
• | an increase in warranty expenses and warranty accruals of $54.9 million associated primarily with an increase in the number of products in our install base as well as an increase in costs related to the different elements of our warranty expenses which include the cost of the products, shipment and other related expenses; |
• | an increase in other production costs of $54.8 million, which is mainly attributed to charges from our contract manufacturers due to manufacturing disruptions related to global supply constraints, increased logistics costs resulting from transportation disruptions, mobilization of components between our different manufacturing sites as well as ramp up costs associated with our new contract manufacturing site in Mexico; |
• | an increase in custom duties of $19.2 million attributed to higher tariff charges due to an increase in volumes sold and the manufacture of a higher portion of our products for the U.S. in China; and; |
• | an increase in personnel-related costs of $15.0 million related to the expansion of our production, operations, and support headcount which grew in parallel to our growing install base worldwide. |
Three months ended September 30, 2022 to 2021 | Nine months ended September 30, 2022 to 2021 | |||||||||||||||||||||||||||||||
2022 | 2021 | Change | 2022 | 2021 | Change | |||||||||||||||||||||||||||
(In thousands) | ||||||||||||||||||||||||||||||||
Research and development | 69,659 | 55,666 | 13,993 | 25.1 | % | 210,855 | 155,307 | 55,548 | 35.8 | % |
• | an increase in personnel-related costs of $9.8 million resulting from an increase in our research and development headcount as well as salary expenses associated with annual merit increases and employee equity-based compensation. The increase in headcount reflects our continued investment in enhancements of existing products as well as research and development expenses associated with bringing new products to the market; |
• | an increase in expenses related to other overhead costs in an amount of $2.4 million; and |
• | an increase in depreciation expenses of property and equipment in an amount of $1.4 million. |
• | an increase in personnel-related costs of $43.0 million resulting from an increase in our research and development headcount as well as salary expenses associated with annual merit increases and employee equity-based compensation. The increase in headcount reflects our continued investment in enhancements of existing products as well as research and development expenses associated with bringing new products to the market; |
• | a decrease in reimbursement of costs, related to research and development activities performed by SolarEdge e-Mobility in an amount of $4.2 million; |
• | an increase in expenses related to other overhead costs in an amount of $4.2 million; |
• | an increase in depreciation expenses of property and equipment in an amount of $3.9 million; and |
• | an increase in expenses related to material consumption in the manufacturing of prototypes during our development process in an amount of $2.2 million. |
Three months ended September 30, 2022 to 2021 | Nine months ended September 30, 2022 to 2021 | |||||||||||||||||||||||||||||||
2022 | 2021 | Change | 2022 | 2021 | Change | |||||||||||||||||||||||||||
(In thousands) | ||||||||||||||||||||||||||||||||
Sales and marketing | 42,726 | 29,383 | 13,343 | 45.4 | % | 117,017 | 85,752 | 31,265 | 36.5 | % |
• | an increase in personnel-related costs of $10.3 million as a result of an increase in headcount supporting our growth in all geographies, as well as salary expenses associated with annual merit increases and employee equity-based compensation; |
• | an increase in expenses related to marketing activities by $1.3 million due to the renewal of marketing activities, exhibitions and shows, which were cancelled or postponed in 2021 due to Covid-19 restrictions; and |
• | an increase in expenses related to travel in an amount of $0.8 million. |
• | an increase in personnel-related costs of $21.8 million as a result of an increase in headcount supporting our growth in all geographies, as well as salary expenses associated with annual merit increases and employee equity-based compensation; |
• | an increase in expenses related to marketing activities by $4.2 million due to the renewal of marketing activities, exhibitions and shows, which were cancelled or postponed in 2021 due to Covid-19 restrictions; and |
• | an increase in expenses related to travel in an amount of $2.1 million. |
Three months ended September 30, 2022 to 2021 | Nine months ended September 30, 2022 to 2021 | |||||||||||||||||||||||||||||||
2022 | 2021 | Change | 2022 | 2021 | Change | |||||||||||||||||||||||||||
(In thousands) | ||||||||||||||||||||||||||||||||
General and administrative | 27,933 | 21,098 | 6,835 | 32.4 | % | 82,483 | 60,317 | 22,166 | 36.7 | % |
• | an increase in personnel-related costs of $5.2 million resulting from an increase in our general and administrative headcount, as well as salary expenses associated with annual merit increases and employee equity-based compensation; |
• | an increase in expenses related to consultants and sub-contractors in an amount of $1.0 million; |
• | an increase in expenses related to overhead costs in an amount of $0.6 million; and |
• | an increase in expenses related to doubtful debt in an amount of $0.5 million. |
• | an increase in personnel-related costs of $17.7 million resulting from an increase in our general and administrative headcount, as well as salary expenses associated with annual merit increases and employee equity-based compensation; |
• | an increase in expenses related to consultants and sub-contractors in an amount of $4.3 million; |
• | an increase in expenses related to overhead costs in an amount of $1.7 million; and |
• | an increase in expenses related to doubtful debt in an amount of $1.5 million; |
Three months ended September 30, 2022 to 2021 | Nine months ended September 30, 2022 to 2021 | |||||||||||||||||||||||||||||||
2022 | 2021 | Change | 2022 | 2021 | Change | |||||||||||||||||||||||||||
(In thousands) | ||||||||||||||||||||||||||||||||
Other operating expenses (income), net | (2,724 | ) | — | (2,724 | ) | (100.0 | )% | 1,963 | 1,350 | 613 | 45.4 | % |
• | an increase of $1.6 million in income related to the discontinuation of our UPS related activities and the sale of assets related to these activities. |
• | an increase of $1.1 million in income related to the sale of property, plant and equipment; and |
• | an increase of $4.0 million in expenses related to write-offs of goodwill and intangible assets related to the discontinuation of our UPS related activities; and |
• | a decrease of $0.9 million in income related to a payment made to us from an escrow account with regards to a working capital adjustment in connection with the Kokam acquisition. |
• | a decrease of $1.6 million in expenses related to write-offs of property, plant and equipment; |
• | an increase of $1.6 million in income related to the discontinuation of our UPS related activities and the sale of assets related to these activities; and |
• | an increase of $1.1 million in income related to the sale of property, plant and equipment. |
Three months ended September 30, 2022 to 2021 | Nine months ended September 30, 2022 to 2021 | |||||||||||||||||||||||||||||||
2022 | 2021 | Change | 2022 | 2021 | Change | |||||||||||||||||||||||||||
(In thousands) | ||||||||||||||||||||||||||||||||
Financial expense, net | (33,025 | ) | (5,751 | ) | (27,274 | ) | 474.2 | % | (52,785 | ) | (13,591 | ) | (39,194 | ) | 288.4 | % |
• | an increase of $28.3 million in expenses related to foreign exchange fluctuations, mainly due to the strengthening of the U.S. Dollar against the Euro, the British pound sterling (GBP) and the Australian dollar (AUD) . |
• | an increase of $2.1 million in expenses related to hedging transactions. |
• | an increase of $39.4 million in expenses related to foreign exchange fluctuations, mainly due to the strengthening of the U.S. Dollar against the Euro, the New Israeli Shekel, the GBP and the AUD. |
• | an increase of $2.6 million in expenses related to hedging transactions. |
Three months ended September 30, 2022 to 2021 | Nine months ended September 30, 2022 to 2021 | |||||||||||||||||||||||||||||||
2022 | 2021 | Change | 2022 | 2021 | Change | |||||||||||||||||||||||||||
(In thousands) | ||||||||||||||||||||||||||||||||
Other income | 7,533 | — | 7,533 | 100.0 | % | 7,533 | — | 7,533 | 100.0 | % |
Three months ended September 30, 2022 to 2021 | Nine months ended September 30, 2022 to 2021 | |||||||||||||||||||||||||||||||
2022 | 2021 | Change | 2022 | 2021 | Change | |||||||||||||||||||||||||||
(In thousands) | ||||||||||||||||||||||||||||||||
Income taxes | 34,172 | 7,615 | 26,557 | 348.7 | % | 53,081 | 24,294 | 28,787 | 118.5 | % |
Three months ended September 30, 2022 to 2021 | Nine months ended September 30, 2022 to 2021 | |||||||||||||||||||||||||||||||
2022 | 2021 | Change | 2022 | 2021 | Change | |||||||||||||||||||||||||||
(In thousands) | ||||||||||||||||||||||||||||||||
Net income | 24,743 | 53,048 | (28,305 | ) | (53.4 | )% | 72,950 | 128,216 | (55,266 | ) | (43.1 | )% |
Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||
2022 | 2021 | 2022 | 2021 | |||||||||||||
(In thousands) | ||||||||||||||||
Net cash provided by (used in) operating activities | 5,558 | 61,784 | (80,016 | ) | 124,552 | |||||||||||
Net cash used in investing activities | (54,581 | ) | (61,961 | ) | (380,514 | ) | (397,959 | ) | ||||||||
Net cash provided by (used in) financing activities | (1,271 | ) | 1,774 | 647,135 | (19,432 | ) | ||||||||||
Increase (decrease) in cash and cash equivalents | (50,294 | ) | 1,597 | 186,605 | (292,839 | ) |
Exhibit No. | Description | Incorporation by Reference | ||
Filed with this report. | ||||
Filed with this report. | ||||
Filed with this report. | ||||
Filed with this report. | ||||
101 | The following financial statements from the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2022, formatted in Inline XBRL: (i) Condensed Consolidated Balance Sheets, (ii) Condensed Consolidated Statements of Income, (iii) Condensed Consolidated Statements of Comprehensive Income, (iv) Condensed Consolidated Statements of Stockholders’ Equity, (v) Condensed Consolidated Statements of Cash Flows, and (vi) Notes to Condensed Consolidated Financial Statements | Filed with this report. | ||
104 | The cover page from the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2022 formatted in Inline XBRL | Included in Exhibit 101 |
Date: November 8, 2022 | /s/Zvi Lando |
Zvi Lando | |
Chief Executive Officer | |
(Principal Executive Officer) |
Date: November 8, 2022 | /s/ Ronen Faier |
Ronen Faier | |
Chief Financial Officer | |
(Principal Financial Officer) |
/s/ Zvi Lando
|
Zvi Lando
|
Chief Executive Officer
(Principal Executive Officer)
|
/s/ Ronen Faier
|
Ronen Faier
|
Chief Financial Officer
(Principal Financial Officer)
|
/s/ Zvi Lando
|
Zvi Lando
|
Chief Executive Officer
(Principal Executive Officer)
|
/s/ Ronen Faier
|
Ronen Faier
|
Chief Financial Officer
(Principal Financial Officer)
|